SlideShare a Scribd company logo
Session 4.4: Chronic
Complications of Diabetes
Mellitus
Module 4: Management of
Patient with Diabetes
Mellitus
Learning Objectives
• At the end of this session participants are
expected to be able to:
• Describe long term effects and risk factors
for chronic complications of diabetes
mellitus
• Recognize clinical presentation and
management of chronic complications of
diabetes mellitus
• Prevent chronic complications of diabetes
mellitus
Activity: Buzzing
 What are the long-term effect and risk factors
for chronic complications of diabetes mellitus?
Long Term Effect of Diabetes Mellitus
Risk Factors for Chronic
Complications of Diabetes
Activity: Small Group Discussion
• What is the clinical presentation of
patients with chronic complications of
diabetes mellitus?
Clinical Presentation of Patients with
Chronic Complications of Diabetes
Complications
 Left untreated, chronic hyperglycaemia
damages the small and large blood vessels,
leading to complications such as
 vision defects, kidney failure, numb feet,
heart attack, stroke, peripheral vascular
disease, pain in the back of the legs and
feet problems
Small Vessels (Micro-Vascular)
 There are three micro vascular complications:
• Diabetic retinopathy (diabetes eye disease)
may present with deterioration in vision
(severe or blindness in 12% after 15years)
• Nephropathy (kidney complications) may
present with cloudy urine, weakness,
lethargy or blood in urine
• Neuropathy (nerve complications) may
present as tingling, numbness or loss of
sensation in the feet
Small Vessels (Micro-Vascular) (2)
 Microvascular complications
 Set in early and are more common in
people of African origin because of delay in
the diagnosis
 They are a major cause of illness
(morbidity)
Diabetic Neuropathy
Diabetes neuropathy is:
 Damage to nerves and affects up to 50-60%
of people with diabetes
 Considered a microvascular complication of
diabetes
 Can be focal or diffuse
 Involves peripheral sensory, motor or
autonomic pathways
Diabetic Neuropathy (2)
Most common include:
 Distal symmetrical sensorimotor diabetic
polyneuropathy (DPN)
 Present as tingling, pain, numbness, or
weakness in the feet and hands
 Facilitate development of ulcers due to
external trauma and/or abnormal distribution of
the internal bone pressure
 Autonomic neuropathy involving gastrointestinal,
genitourinary, and cardiovascular systems
 Contribute to hypoglycaemic unawareness
Diabetic Neuropathy (3)
 Lower limb amputation in people with
diabetes is 10 to 20 times more common
compared to those without diabetes
 The risk is higher in low- and middle-income
countries
Retinopathy
 Diabetes retinopathy is the leading cause of
blindness in middle-aged population
 Annual dilated ophthalmologic evaluations
are recommended to monitor retinopathy
 Newly diagnosed T1DM patients should have
an initial dilated eye examination within 3 to 5
years after onset of their disease
 Person with T2DM should have a
comprehensive eye examination at the time
of diagnosis and yearly thereafter
Retinopathy (2)
 Laser photocoagulation therapy has been the
mainstay treatment for preservation of vision
in diabetic retinopathy, but it does not restore
lost vision
 Close ophthalmologic follow-up is
recommended to determine the timing and
extent of laser or other therapies
Nephropathy
Diabetes nephropathy:
 Accounts for nearly 50% of end-stage renal
disease
 Is a leading cause of diabetes-related
morbidity and mortality
 Its earliest sign is microalbuminuria, defined
as albumin to creatinine ratio in a spot urine
sample of 30 to 300mcg/mg
Nephropathy (2)
 Macroalbuminuria
 Defined as a albumin: creatinine ratio
≥300mcg/mg
 Carries a worse prognosis with regard to
progression of kidney disease and need for
renal replacement therapy
 Testing for albuminuria:
 For T1DM: Within 5 years of diagnosis,
then annually
 For T2DM: at the time of diagnosis, then
annually
Nephropathy (3)
 Serum creatinine:
 Measure annually for both T1DM and
T2DM
 Calculate eGFR and refer to Nephrologist
all patients with eGFR < 60ml/min
regardless of aetiology
Large vessels (Macro-vascular)
Complications
 Cardiovascular disease is the leading
cause of mortality in patients with diabetes
 Diabetes confers an increased risk of:
 Acute coronary syndrome
 Myocardial infarction
 Heart failure
 Atrial fibrillation, stroke, peripheral vascular
disease and sudden death are 2 to 5 times
the risk in nondiabetic comparator groups
Large vessels (Macro-vascular)
Complications (2)
 Heart attack, angina (the most common
complication of diabetes) can present as chest
pains, shortness of breath and sweating
 Stroke presents as weakness or paralysis of
limbs, face
 Peripheral vascular disease, presents as
pain in the back of the leg on walking
 Poor blood flow in the feet, leading to
infections and ulcers
 Poor blood flow in the penis may lead to
impotence
Hypertension
 Hypertension is present in:
 > 75% of persons with T2DM
 > 50% of persons with T1DM
 BP reduction:
 Reduces the frequency of myocardial
infarction, cerebrovascular disease, and
diabetes-related deaths
 Slows the progression of nephropathy,
retinopathy, and vision loss
 Blood pressure should be checked at every
visit in patients with diabetes
Hypertension (2)
Lifestyle therapy and medical treatment for
hypertension in people with diabetes
• Considered if BP ≥ 130/80mmhg
• Includes weight loss, low salt, low fat and low
carbohydrate diet, and moderation of alcohol
intake
• Stop smoking cigarette
• Increased physical activity
Hypertension (3)
 Use Angiotensin-converting enzyme
Inhibitors (ACEIs) or Angiotensin receptor
blockers (ARBs) as initial therapy because:
 Proven benefit in lowering cardiovascular
mortality
 Decreased progression of both retinopathy
and nephropathy in individual with diabetes
 Second and third-line treatment with diuretics
 B-blockers or calcium channel blockers
should be tailored to the individual patient
Impaired Immune System
 Prolonged high blood glucose (chronic
hyperglycaemia) leads to a weakening of
immune system
 As a result, patients get recurrent bacterial
and fungal infections of penis, vagina, skin,
eye, urinary tract, respiratory tract (coughs,
colds)
 They are also more prone to getting
tuberculosis (TB)
Hyperlipidaemia
 Diabetic patients should have a fasting lipid
profile (total cholesterol, low-density
lipoprotein LDL, HDL-cholesterol and
Triglycerides)
 Check yearly
 Treat with statin therapy to achieve normal
targets
Activity: Buzzing
 How do you prevent chronic
complications of diabetes mellitus?
Prevention of Chronic
Complications of Diabetes Mellitus
 Slow, chronic hyperglycaemia is the source of
most diabetic illness and death
 Cardiovascular and microvascular
complications may be prevented or delayed
when glycaemic levels are controlled
 Microvascular complications could be
significantly reduced up to 70% when
glycaemic goals are within near-normal levels
(NIDDK, 2008)
Prevention of Chronic Complications
of Diabetes Mellitus (2)
Primary Prevention
 Includes activities aimed at preventing
diabetes from occurring in susceptible
populations
Secondary Prevention
 Early diagnosis and effective control of
diabetes in order to delay the progress of
the disease
Tertiary Prevention
 Prevent complications and disabilities due
to diabetes
Prevention of Chronic Complications
of Diabetes Mellitus (6)
Key Points
 Long term effects of hyperglycaemia
include kidney diseases, heart diseases,
eye diseases, and nerve diseases
 Risk factors for chronic complications of
diabetes other than hyperglycaemia
include genetic susceptibility and
environmental factors such as nutrition,
obesity and physical inactivity
Key Points (2)
 Left untreated, chronic hyperglycaemia
damages the small and large blood vessels,
leading to complications such as:
 vision defects, kidney failure, numb feet,
heart attack, stroke, peripheral vascular
disease, pain in the back of the legs and
feet problems
 Prevention includes primary, secondary and
tertiary
Session Evaluation
 What are the chronic complications of
diabetes mellitus?
 How can you prevent these
complications?

More Related Content

Similar to NCD Training Module 4.4 Chronic Complication of Diabetic Mellitus.ppt

Non communicable diseases
Non communicable diseasesNon communicable diseases
Non communicable diseases
Devipriya Viswambharan
 
Management of Diabetic Nephropathy
Management of Diabetic NephropathyManagement of Diabetic Nephropathy
Management of Diabetic Nephropathy
drsanjaymaitra
 
diabetes-mellitus3143.pptx
diabetes-mellitus3143.pptxdiabetes-mellitus3143.pptx
diabetes-mellitus3143.pptx
MubashirHussan2
 
Diabetic retinopathy
Diabetic retinopathyDiabetic retinopathy
Diabetic retinopathy
Anjali Maheshwari
 
Diabetes-related Clinical Complications: Novel Approaches for Diagnosis and M...
Diabetes-related Clinical Complications: Novel Approaches for Diagnosis and M...Diabetes-related Clinical Complications: Novel Approaches for Diagnosis and M...
Diabetes-related Clinical Complications: Novel Approaches for Diagnosis and M...
asclepiuspdfs
 
Important file _0000.pptx
Important  file _0000.pptxImportant  file _0000.pptx
Important file _0000.pptx
SaaminNaveera
 
Diabesity with Sharon Weinstein
Diabesity with Sharon WeinsteinDiabesity with Sharon Weinstein
Diabesity with Sharon Weinstein
HPCareer.Net / State of Wellness Inc.
 
DIABETES MELLITUS AND DIABETIC EYE DISEASE
DIABETES MELLITUS AND DIABETIC EYE DISEASEDIABETES MELLITUS AND DIABETIC EYE DISEASE
DIABETES MELLITUS AND DIABETIC EYE DISEASEHossein Mirzaie
 
4441564759967.pptx
4441564759967.pptx4441564759967.pptx
4441564759967.pptx
biruktesfaye27
 
Slides
SlidesSlides
Rotarians and Diabetes Prevention Developing Healthy Communities: Part 1 rag ...
Rotarians and Diabetes Prevention Developing Healthy Communities: Part 1 rag ...Rotarians and Diabetes Prevention Developing Healthy Communities: Part 1 rag ...
Rotarians and Diabetes Prevention Developing Healthy Communities: Part 1 rag ...Rotary International
 
Rotarians and Diabetes Prevention Developing Healthy Communities: Part 1 rag ...
Rotarians and Diabetes Prevention Developing Healthy Communities: Part 1 rag ...Rotarians and Diabetes Prevention Developing Healthy Communities: Part 1 rag ...
Rotarians and Diabetes Prevention Developing Healthy Communities: Part 1 rag ...
KouameK
 
Smoking and diabetes
Smoking and diabetesSmoking and diabetes
Smoking and diabetes
ahmad mohd
 
Scleroderma
SclerodermaScleroderma
Sclerodermadrmomusa
 
Ueda 2016 7-diabetic complications - adel el sayed
Ueda 2016 7-diabetic complications -  adel el sayedUeda 2016 7-diabetic complications -  adel el sayed
Ueda 2016 7-diabetic complications - adel el sayed
ueda2015
 
Diabetes Mellitus.ppsx
Diabetes Mellitus.ppsxDiabetes Mellitus.ppsx
Diabetes Mellitus.ppsx
Akhilesh bhura
 
Diabetis.pptx
Diabetis.pptxDiabetis.pptx
Diabetis.pptx
AbdullahAlJalil
 
Diabetes-Related Complications: Key Insights
Diabetes-Related Complications: Key InsightsDiabetes-Related Complications: Key Insights
Diabetes-Related Complications: Key Insights
Shivankan Kakkar
 
Lecture 3: Diabetic Retinopathy
Lecture 3: Diabetic RetinopathyLecture 3: Diabetic Retinopathy
Lecture 3: Diabetic Retinopathy
Munish Sharma MD OD
 
Diabetes Presentation Nosscr 52010
Diabetes Presentation Nosscr 52010Diabetes Presentation Nosscr 52010
Diabetes Presentation Nosscr 52010
Law Firm
 

Similar to NCD Training Module 4.4 Chronic Complication of Diabetic Mellitus.ppt (20)

Non communicable diseases
Non communicable diseasesNon communicable diseases
Non communicable diseases
 
Management of Diabetic Nephropathy
Management of Diabetic NephropathyManagement of Diabetic Nephropathy
Management of Diabetic Nephropathy
 
diabetes-mellitus3143.pptx
diabetes-mellitus3143.pptxdiabetes-mellitus3143.pptx
diabetes-mellitus3143.pptx
 
Diabetic retinopathy
Diabetic retinopathyDiabetic retinopathy
Diabetic retinopathy
 
Diabetes-related Clinical Complications: Novel Approaches for Diagnosis and M...
Diabetes-related Clinical Complications: Novel Approaches for Diagnosis and M...Diabetes-related Clinical Complications: Novel Approaches for Diagnosis and M...
Diabetes-related Clinical Complications: Novel Approaches for Diagnosis and M...
 
Important file _0000.pptx
Important  file _0000.pptxImportant  file _0000.pptx
Important file _0000.pptx
 
Diabesity with Sharon Weinstein
Diabesity with Sharon WeinsteinDiabesity with Sharon Weinstein
Diabesity with Sharon Weinstein
 
DIABETES MELLITUS AND DIABETIC EYE DISEASE
DIABETES MELLITUS AND DIABETIC EYE DISEASEDIABETES MELLITUS AND DIABETIC EYE DISEASE
DIABETES MELLITUS AND DIABETIC EYE DISEASE
 
4441564759967.pptx
4441564759967.pptx4441564759967.pptx
4441564759967.pptx
 
Slides
SlidesSlides
Slides
 
Rotarians and Diabetes Prevention Developing Healthy Communities: Part 1 rag ...
Rotarians and Diabetes Prevention Developing Healthy Communities: Part 1 rag ...Rotarians and Diabetes Prevention Developing Healthy Communities: Part 1 rag ...
Rotarians and Diabetes Prevention Developing Healthy Communities: Part 1 rag ...
 
Rotarians and Diabetes Prevention Developing Healthy Communities: Part 1 rag ...
Rotarians and Diabetes Prevention Developing Healthy Communities: Part 1 rag ...Rotarians and Diabetes Prevention Developing Healthy Communities: Part 1 rag ...
Rotarians and Diabetes Prevention Developing Healthy Communities: Part 1 rag ...
 
Smoking and diabetes
Smoking and diabetesSmoking and diabetes
Smoking and diabetes
 
Scleroderma
SclerodermaScleroderma
Scleroderma
 
Ueda 2016 7-diabetic complications - adel el sayed
Ueda 2016 7-diabetic complications -  adel el sayedUeda 2016 7-diabetic complications -  adel el sayed
Ueda 2016 7-diabetic complications - adel el sayed
 
Diabetes Mellitus.ppsx
Diabetes Mellitus.ppsxDiabetes Mellitus.ppsx
Diabetes Mellitus.ppsx
 
Diabetis.pptx
Diabetis.pptxDiabetis.pptx
Diabetis.pptx
 
Diabetes-Related Complications: Key Insights
Diabetes-Related Complications: Key InsightsDiabetes-Related Complications: Key Insights
Diabetes-Related Complications: Key Insights
 
Lecture 3: Diabetic Retinopathy
Lecture 3: Diabetic RetinopathyLecture 3: Diabetic Retinopathy
Lecture 3: Diabetic Retinopathy
 
Diabetes Presentation Nosscr 52010
Diabetes Presentation Nosscr 52010Diabetes Presentation Nosscr 52010
Diabetes Presentation Nosscr 52010
 

Recently uploaded

How to Break the cycle of negative Thoughts
How to Break the cycle of negative ThoughtsHow to Break the cycle of negative Thoughts
How to Break the cycle of negative Thoughts
Col Mukteshwar Prasad
 
Students, digital devices and success - Andreas Schleicher - 27 May 2024..pptx
Students, digital devices and success - Andreas Schleicher - 27 May 2024..pptxStudents, digital devices and success - Andreas Schleicher - 27 May 2024..pptx
Students, digital devices and success - Andreas Schleicher - 27 May 2024..pptx
EduSkills OECD
 
MARUTI SUZUKI- A Successful Joint Venture in India.pptx
MARUTI SUZUKI- A Successful Joint Venture in India.pptxMARUTI SUZUKI- A Successful Joint Venture in India.pptx
MARUTI SUZUKI- A Successful Joint Venture in India.pptx
bennyroshan06
 
Digital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and ResearchDigital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and Research
Vikramjit Singh
 
Ethnobotany and Ethnopharmacology ......
Ethnobotany and Ethnopharmacology ......Ethnobotany and Ethnopharmacology ......
Ethnobotany and Ethnopharmacology ......
Ashokrao Mane college of Pharmacy Peth-Vadgaon
 
Template Jadual Bertugas Kelas (Boleh Edit)
Template Jadual Bertugas Kelas (Boleh Edit)Template Jadual Bertugas Kelas (Boleh Edit)
Template Jadual Bertugas Kelas (Boleh Edit)
rosedainty
 
The Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official PublicationThe Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official Publication
Delapenabediema
 
How to Create Map Views in the Odoo 17 ERP
How to Create Map Views in the Odoo 17 ERPHow to Create Map Views in the Odoo 17 ERP
How to Create Map Views in the Odoo 17 ERP
Celine George
 
Fish and Chips - have they had their chips
Fish and Chips - have they had their chipsFish and Chips - have they had their chips
Fish and Chips - have they had their chips
GeoBlogs
 
Chapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptxChapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptx
Mohd Adib Abd Muin, Senior Lecturer at Universiti Utara Malaysia
 
Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
Jisc
 
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
EugeneSaldivar
 
Palestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptxPalestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptx
RaedMohamed3
 
The geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideasThe geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideas
GeoBlogs
 
Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345
beazzy04
 
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
siemaillard
 
ESC Beyond Borders _From EU to You_ InfoPack general.pdf
ESC Beyond Borders _From EU to You_ InfoPack general.pdfESC Beyond Borders _From EU to You_ InfoPack general.pdf
ESC Beyond Borders _From EU to You_ InfoPack general.pdf
Fundacja Rozwoju Społeczeństwa Przedsiębiorczego
 
GIÁO ÁN DẠY THÊM (KẾ HOẠCH BÀI BUỔI 2) - TIẾNG ANH 8 GLOBAL SUCCESS (2 CỘT) N...
GIÁO ÁN DẠY THÊM (KẾ HOẠCH BÀI BUỔI 2) - TIẾNG ANH 8 GLOBAL SUCCESS (2 CỘT) N...GIÁO ÁN DẠY THÊM (KẾ HOẠCH BÀI BUỔI 2) - TIẾNG ANH 8 GLOBAL SUCCESS (2 CỘT) N...
GIÁO ÁN DẠY THÊM (KẾ HOẠCH BÀI BUỔI 2) - TIẾNG ANH 8 GLOBAL SUCCESS (2 CỘT) N...
Nguyen Thanh Tu Collection
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
Celine George
 
Language Across the Curriculm LAC B.Ed.
Language Across the  Curriculm LAC B.Ed.Language Across the  Curriculm LAC B.Ed.
Language Across the Curriculm LAC B.Ed.
Atul Kumar Singh
 

Recently uploaded (20)

How to Break the cycle of negative Thoughts
How to Break the cycle of negative ThoughtsHow to Break the cycle of negative Thoughts
How to Break the cycle of negative Thoughts
 
Students, digital devices and success - Andreas Schleicher - 27 May 2024..pptx
Students, digital devices and success - Andreas Schleicher - 27 May 2024..pptxStudents, digital devices and success - Andreas Schleicher - 27 May 2024..pptx
Students, digital devices and success - Andreas Schleicher - 27 May 2024..pptx
 
MARUTI SUZUKI- A Successful Joint Venture in India.pptx
MARUTI SUZUKI- A Successful Joint Venture in India.pptxMARUTI SUZUKI- A Successful Joint Venture in India.pptx
MARUTI SUZUKI- A Successful Joint Venture in India.pptx
 
Digital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and ResearchDigital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and Research
 
Ethnobotany and Ethnopharmacology ......
Ethnobotany and Ethnopharmacology ......Ethnobotany and Ethnopharmacology ......
Ethnobotany and Ethnopharmacology ......
 
Template Jadual Bertugas Kelas (Boleh Edit)
Template Jadual Bertugas Kelas (Boleh Edit)Template Jadual Bertugas Kelas (Boleh Edit)
Template Jadual Bertugas Kelas (Boleh Edit)
 
The Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official PublicationThe Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official Publication
 
How to Create Map Views in the Odoo 17 ERP
How to Create Map Views in the Odoo 17 ERPHow to Create Map Views in the Odoo 17 ERP
How to Create Map Views in the Odoo 17 ERP
 
Fish and Chips - have they had their chips
Fish and Chips - have they had their chipsFish and Chips - have they had their chips
Fish and Chips - have they had their chips
 
Chapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptxChapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptx
 
Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
 
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
 
Palestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptxPalestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptx
 
The geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideasThe geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideas
 
Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345
 
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
 
ESC Beyond Borders _From EU to You_ InfoPack general.pdf
ESC Beyond Borders _From EU to You_ InfoPack general.pdfESC Beyond Borders _From EU to You_ InfoPack general.pdf
ESC Beyond Borders _From EU to You_ InfoPack general.pdf
 
GIÁO ÁN DẠY THÊM (KẾ HOẠCH BÀI BUỔI 2) - TIẾNG ANH 8 GLOBAL SUCCESS (2 CỘT) N...
GIÁO ÁN DẠY THÊM (KẾ HOẠCH BÀI BUỔI 2) - TIẾNG ANH 8 GLOBAL SUCCESS (2 CỘT) N...GIÁO ÁN DẠY THÊM (KẾ HOẠCH BÀI BUỔI 2) - TIẾNG ANH 8 GLOBAL SUCCESS (2 CỘT) N...
GIÁO ÁN DẠY THÊM (KẾ HOẠCH BÀI BUỔI 2) - TIẾNG ANH 8 GLOBAL SUCCESS (2 CỘT) N...
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
 
Language Across the Curriculm LAC B.Ed.
Language Across the  Curriculm LAC B.Ed.Language Across the  Curriculm LAC B.Ed.
Language Across the Curriculm LAC B.Ed.
 

NCD Training Module 4.4 Chronic Complication of Diabetic Mellitus.ppt

  • 1. Session 4.4: Chronic Complications of Diabetes Mellitus Module 4: Management of Patient with Diabetes Mellitus
  • 2. Learning Objectives • At the end of this session participants are expected to be able to: • Describe long term effects and risk factors for chronic complications of diabetes mellitus • Recognize clinical presentation and management of chronic complications of diabetes mellitus • Prevent chronic complications of diabetes mellitus
  • 3. Activity: Buzzing  What are the long-term effect and risk factors for chronic complications of diabetes mellitus?
  • 4. Long Term Effect of Diabetes Mellitus
  • 5. Risk Factors for Chronic Complications of Diabetes
  • 6. Activity: Small Group Discussion • What is the clinical presentation of patients with chronic complications of diabetes mellitus?
  • 7. Clinical Presentation of Patients with Chronic Complications of Diabetes
  • 8. Complications  Left untreated, chronic hyperglycaemia damages the small and large blood vessels, leading to complications such as  vision defects, kidney failure, numb feet, heart attack, stroke, peripheral vascular disease, pain in the back of the legs and feet problems
  • 9. Small Vessels (Micro-Vascular)  There are three micro vascular complications: • Diabetic retinopathy (diabetes eye disease) may present with deterioration in vision (severe or blindness in 12% after 15years) • Nephropathy (kidney complications) may present with cloudy urine, weakness, lethargy or blood in urine • Neuropathy (nerve complications) may present as tingling, numbness or loss of sensation in the feet
  • 10. Small Vessels (Micro-Vascular) (2)  Microvascular complications  Set in early and are more common in people of African origin because of delay in the diagnosis  They are a major cause of illness (morbidity)
  • 11. Diabetic Neuropathy Diabetes neuropathy is:  Damage to nerves and affects up to 50-60% of people with diabetes  Considered a microvascular complication of diabetes  Can be focal or diffuse  Involves peripheral sensory, motor or autonomic pathways
  • 12. Diabetic Neuropathy (2) Most common include:  Distal symmetrical sensorimotor diabetic polyneuropathy (DPN)  Present as tingling, pain, numbness, or weakness in the feet and hands  Facilitate development of ulcers due to external trauma and/or abnormal distribution of the internal bone pressure  Autonomic neuropathy involving gastrointestinal, genitourinary, and cardiovascular systems  Contribute to hypoglycaemic unawareness
  • 13. Diabetic Neuropathy (3)  Lower limb amputation in people with diabetes is 10 to 20 times more common compared to those without diabetes  The risk is higher in low- and middle-income countries
  • 14. Retinopathy  Diabetes retinopathy is the leading cause of blindness in middle-aged population  Annual dilated ophthalmologic evaluations are recommended to monitor retinopathy  Newly diagnosed T1DM patients should have an initial dilated eye examination within 3 to 5 years after onset of their disease  Person with T2DM should have a comprehensive eye examination at the time of diagnosis and yearly thereafter
  • 15. Retinopathy (2)  Laser photocoagulation therapy has been the mainstay treatment for preservation of vision in diabetic retinopathy, but it does not restore lost vision  Close ophthalmologic follow-up is recommended to determine the timing and extent of laser or other therapies
  • 16. Nephropathy Diabetes nephropathy:  Accounts for nearly 50% of end-stage renal disease  Is a leading cause of diabetes-related morbidity and mortality  Its earliest sign is microalbuminuria, defined as albumin to creatinine ratio in a spot urine sample of 30 to 300mcg/mg
  • 17. Nephropathy (2)  Macroalbuminuria  Defined as a albumin: creatinine ratio ≥300mcg/mg  Carries a worse prognosis with regard to progression of kidney disease and need for renal replacement therapy  Testing for albuminuria:  For T1DM: Within 5 years of diagnosis, then annually  For T2DM: at the time of diagnosis, then annually
  • 18. Nephropathy (3)  Serum creatinine:  Measure annually for both T1DM and T2DM  Calculate eGFR and refer to Nephrologist all patients with eGFR < 60ml/min regardless of aetiology
  • 19. Large vessels (Macro-vascular) Complications  Cardiovascular disease is the leading cause of mortality in patients with diabetes  Diabetes confers an increased risk of:  Acute coronary syndrome  Myocardial infarction  Heart failure  Atrial fibrillation, stroke, peripheral vascular disease and sudden death are 2 to 5 times the risk in nondiabetic comparator groups
  • 20. Large vessels (Macro-vascular) Complications (2)  Heart attack, angina (the most common complication of diabetes) can present as chest pains, shortness of breath and sweating  Stroke presents as weakness or paralysis of limbs, face  Peripheral vascular disease, presents as pain in the back of the leg on walking  Poor blood flow in the feet, leading to infections and ulcers  Poor blood flow in the penis may lead to impotence
  • 21. Hypertension  Hypertension is present in:  > 75% of persons with T2DM  > 50% of persons with T1DM  BP reduction:  Reduces the frequency of myocardial infarction, cerebrovascular disease, and diabetes-related deaths  Slows the progression of nephropathy, retinopathy, and vision loss  Blood pressure should be checked at every visit in patients with diabetes
  • 22. Hypertension (2) Lifestyle therapy and medical treatment for hypertension in people with diabetes • Considered if BP ≥ 130/80mmhg • Includes weight loss, low salt, low fat and low carbohydrate diet, and moderation of alcohol intake • Stop smoking cigarette • Increased physical activity
  • 23. Hypertension (3)  Use Angiotensin-converting enzyme Inhibitors (ACEIs) or Angiotensin receptor blockers (ARBs) as initial therapy because:  Proven benefit in lowering cardiovascular mortality  Decreased progression of both retinopathy and nephropathy in individual with diabetes  Second and third-line treatment with diuretics  B-blockers or calcium channel blockers should be tailored to the individual patient
  • 24. Impaired Immune System  Prolonged high blood glucose (chronic hyperglycaemia) leads to a weakening of immune system  As a result, patients get recurrent bacterial and fungal infections of penis, vagina, skin, eye, urinary tract, respiratory tract (coughs, colds)  They are also more prone to getting tuberculosis (TB)
  • 25. Hyperlipidaemia  Diabetic patients should have a fasting lipid profile (total cholesterol, low-density lipoprotein LDL, HDL-cholesterol and Triglycerides)  Check yearly  Treat with statin therapy to achieve normal targets
  • 26. Activity: Buzzing  How do you prevent chronic complications of diabetes mellitus?
  • 27. Prevention of Chronic Complications of Diabetes Mellitus  Slow, chronic hyperglycaemia is the source of most diabetic illness and death  Cardiovascular and microvascular complications may be prevented or delayed when glycaemic levels are controlled  Microvascular complications could be significantly reduced up to 70% when glycaemic goals are within near-normal levels (NIDDK, 2008)
  • 28. Prevention of Chronic Complications of Diabetes Mellitus (2) Primary Prevention  Includes activities aimed at preventing diabetes from occurring in susceptible populations Secondary Prevention  Early diagnosis and effective control of diabetes in order to delay the progress of the disease Tertiary Prevention  Prevent complications and disabilities due to diabetes
  • 29. Prevention of Chronic Complications of Diabetes Mellitus (6)
  • 30. Key Points  Long term effects of hyperglycaemia include kidney diseases, heart diseases, eye diseases, and nerve diseases  Risk factors for chronic complications of diabetes other than hyperglycaemia include genetic susceptibility and environmental factors such as nutrition, obesity and physical inactivity
  • 31. Key Points (2)  Left untreated, chronic hyperglycaemia damages the small and large blood vessels, leading to complications such as:  vision defects, kidney failure, numb feet, heart attack, stroke, peripheral vascular disease, pain in the back of the legs and feet problems  Prevention includes primary, secondary and tertiary
  • 32. Session Evaluation  What are the chronic complications of diabetes mellitus?  How can you prevent these complications?

Editor's Notes

  1. 6/22/2023
  2. REVIEW learning objectives with participants. CLARIFY any questions they may have before moving on.
  3. Activity: Buzzing (5 minutes) ASK participants to brainstorm on the following question: What are the long term effect and risk factors for chronic complications of diabetes mellitus? ALLOW few participants to respond WRITE their responses on the flip chart/ board CLARIFY and SUMMARISE by using the content below
  4. Activity: Small Group Discussion (15 Minutes) DIVIDE participants into small manageable groups to discuss on the following question: What is the clinical presentation of patients with chronic complications of diabetes mellitus? ALLOW few groups to present and the rest to add on points not mentioned WRITE their responses on the flip chart/board CLARIFY and SUMMARIZE by using the content below
  5. REFER participants to participants manual page xxx for information on complications
  6. Activity: Buzzing (5 minutes) ASK participants to buzz on the following question for 2 minutes: How do you prevent chronic complications of diabetes mellitus? ALLOW few participants to respond WRITE their responses on the flip chart/ board CLARIFY and SUMMARISE by using the content below